Wizermed

@Wizermed is proud to be mentioned in the Italian press (Italian Language), following the @zambon Open Accelerator Demo day that took place at the OpenZone scientific campus near Milan. https://lnkd.in/evP64zmg https://lnkd.in/exdFXjUK Interesting quotes: 1. "... a fundamental objective carried out by Open Accelerator 2024, that is to put women's health at the center through the ambitious acceleration program promoted by Zcube - Zambon Research Venture to support innovation in the life sciences sector. This year's edition can boast 185 applications from all over the world, 5 selected startups, 27 mentors and 18 partner organizations" 2. About Wizermed: "The use of the most modern technologies, such as artificial intelligence, in this case used for the predictive monitoring of migraine symptoms" 3. About investing in Woman's health: It is estimated that addressing the health gap in women's health, through increased public spending and market investments, could boost the global economy by $1 trillion per year by 2040, equivalent to a 1.7% increase in GDP per capita.

Guy Attar, our CEO, presents Wizermed’s mission to empower women to predict their migraines and take control of their condition, in front of pharma and biotech professionals and italian investors in the Zambon OA event in Milan.

Many thanks to the Zambon Open Accelerator for choosing Wizermed and for the opportunity to present in front of so many investors and industry proffessionals about migraine prediction and Woman’s health. It was our honor to be part of the program!

We are thrilled to announce that Wizermed has been selected for the fifth edition of Open Accelerator, the Zcube-Zambon Research Venture’s international life sciences acceleration program this year focused on women’s health. Starting from today at the OpenZone scientific campus, we will embark on this incredible journey of growth, opportunity, and networking. Out of 185 applications from around the world, we are proud to be one of the five companies selected for our innovative personalized migraine management product by the esteemed pharmaceutical company Zambon. Participating in this program is a major milestone for our company, further reinforcing our business strategy and commitment to advancing women's health. OpenZone Zambon #womanshealth #femtech #healthcareinnovation #migraine #openaccelerator

We are pleased to announce that Dr. Richard B. Lipton has joined the Wizermed family as our Scientific Advisory Board member. Dr. Lipton is a Professor of Neurology, Epidemiology and Population Health at Albert Einstein College of Medicine, a world leading migraine researcher. Supported by his extensive experiences in the migraine space, Dr. Lipton brings to the table an cutting-edge expertise on migraine innovation. Dr. Lipton has a longstanding interest in using technology to identify and treat predictable headaches. He believes that Wizermed is well positioned to transform migraine care through its novel approaches to collecting and analyzing data.  The vision of Dr. Lipton for a future of patient care for migraine patients aligns with our very mission here at Wizermed. With the addition of Dr. Lipton to our team, WizerMed will aim to reach new heights in treatment for migraine management! #migraineresearch #migraine #migrainemanagement #digitalhealth #medicaldevice richard lipton

We're are welcoming angel investors to join us in developing breakthrough solutions for migraine management. Reach out to explore the terms of our current round. #digitalhealth #healthtech #vc #migraine

🚀 Exciting News Alert! 🚀  We are thrilled to announce the newest additions to Wizermed's Board of Directors: Talor Sax, CEO of eHealth Ventures and a visionary leader in health-tech, and Joseph Rosenblum, Chief Medical Officer at eHealth Ventures bringing 30+ years of expertise in Healthcare IT. Their wealth of experience and strategic insights will undoubtedly propel us to new heights. Welcome aboard!   We're still welcoming angel investors to join us in our exciting venture. Don't miss this opportunity, reach out to explore the incredible terms of our round!! Feel free to reach out to Guy Attar for more information.  #digitalhealth #healthtech #vc #migraine

Join Our Pioneering Migraine Study! 🚀 Sarid Research is proud to partner with Wizermed in a cutting-edge study aimed at combating migraines through AI-driven solutions. Wizermed's solutions have the potential to improve the lives of millions suffering from migraines. If you're located in Israel and suffering from migraines there's an opportunity for you to contribute to this breakthrough in medical research as well: as a participant, you’ll not only help advance migraine research but also receive a Garmin smartwatch ⌚ that plays a crucial role in the AI-driven solutions that Wizermed's team is working on. Ready to be a pioneer? Connect with us at https://lnkd.in/dgwyQZ4y and take a step towards a future free from migraines. Thanks to Dan Yamin, Erez Shmueli, and Guy Attar for the opportunity to collaborate with them on this important project. #MigrainePioneers #AIForGood #ClinicalResearch #SmartTechnology #HealthcareInnovation #ParticipateNow

If you have acquaintances or family in israel who suffers from Migrains, there is the opportunity for them to participate in this breakthrough research. Please share the message with them! Wizermed Garmin

We're #hiring a new Junior Data Scientist (Student Job) in Tel Aviv District. Apply today or share this post with your network.